The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production

English version České info

Hepatitis C virus (HCV) infection can lead to significant liver disease and, without a vaccine, continues to pose a significant public health threat. The viral p7 protein is a multifunctional protein that is required for infectious virus production via its role in orchestrating virion assembly and its activity as an ion channel. However, while there is accumulating structural information on p7, there is no consensus on which conformation(s) exist during a natural infection or how structural elements relate to p7 functions. By comparing two prominent, yet highly divergent models of p7, we identified one region of structural similarity–the N-terminal helical region. While mutagenesis screening of other regions of the protein are in keeping with p7 conformational flexibility, mutations within the N-terminal helical region had a significant impact on infectious virus production, due in part to a loss of efficient E2/p7 cleavage. We further postulated the precise functional impact of mutations throughout p7 by homology modeling and demonstrated tolerance for diverse amino acid substitutions for specific N-terminal helix residues with putative ion channel defects. Together, these data not only support p7 as a structurally plastic, minimalistic ion channel, but also provide extensive insight into the p7 structure-function relationship and highlight the importance of the N-terminal helical region in E2/p7 processing, protein-protein interactions, ion channel activity, and infectious HCV production.

Vyšlo v časopise: The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production. PLoS Pathog 11(11): e32767. doi:10.1371/journal.ppat.1005297
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1005297

Souhrn

Zdroje

1. Lavanchy D. The global burden of hepatitis C. Liver International. 2009;29:74–81. doi: 10.1111/j.1478-3231.2008.01934.x WOS:000262646800011.

2. Brown RS. Hepatitis C and liver transplantation. Nature. 2005;436(7053):973–8. doi: 10.1038/nature04083 WOS:000231263900040.

3. Razavi H, ElKhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013;57(6):2164–70. doi: 10.1002/hep.26218 WOS:000320276400012.

4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral-hepatitis genome. Science. 1989;244(4902):359–62. doi: 10.1126/science.2523562 WOS:A1989U213700036.

5. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Archives of Virology. 1998;143(12):2493–503. doi: 10.1007/s007050050479 WOS:000078586500020.

6. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nature Reviews Microbiology. 2007;5(6):453–63. doi: 10.1038/nrmicro1645 WOS:000246603700014.

7. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM. Processing in the hepatitis-C virus E2-NS2 region—identification of p7 and 2 distinct E2-specific products with different C-termini. Journal of Virology. 1994;68(8):5063–73. WOS:A1994NW97800040.

8. Madan V, Bartenschlager R. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses. 2015;7(8):4461–81. doi: 10.3390/v7082826 MEDLINE:26258788.

9. Vieyres G, Brohm C, Friesland M, Gentzsch J, Woelk B, Roingeard P, et al. Subcellular Localization and Function of an Epitope-Tagged p7 Viroporin in Hepatitis C Virus-Producing Cells. Journal of Virology. 2013;87(3):1664–78. doi: 10.1128/jvi.02782-12 WOS:000313558100033.

10. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285(5424):110–3. doi: 10.1126/science.285.5424.110 WOS:000081199800042.

11. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. Journal of Virology. 2007;81(16):8374–83. doi: 10.1128/jvi.00690-07 WOS:000248649100001.

12. Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. Plos Pathogens. 2007;3(7):962–71. doi: 10.1371/journal.ppat.0030103 WOS:000248511600011

13. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. Journal of Experimental Medicine. 2003;197(5):633–42. doi: 10.1084/jem.20021756 WOS:000181411400010

14. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(12):7271–6. doi: 10.1073/pnas.0832180100 WOS:000183493500068.

15. Boson B, Granio O, Bartenschlager R, Cosset F- L. A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly. Plos Pathogens. 2011;7(7). doi: 10.1371/journal.ppat.1002144 WOS:000293339300032.

16. Jirasko V, Montserret R, Lee JY, Gouttenoire J, Moradpour D, Penin F, et al. Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly. Plos Pathogens. 2010;6(12). doi: 10.1371/journal.ppat.1001233 WOS:000285587500021.

17. Gentzsch J, Brohm C, Steinmann E, Friesland M, Menzel N, Vieyres G, et al. Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment. Plos Pathogens. 2013;9(5). doi: 10.1371/journal.ppat.1003355 WOS:000320032800032.

18. Carrere-Kremer S, Montpellier-Pala C, Cocquerel L, Wychowski C, Penin F, Dubuisson J. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. Journal of Virology. 2002;76(8):3720–30. doi: 10.1128/jvi.76.8.3720–3730.2002 WOS:000174520600014.

19. Ma Y, Anantpadma M, Timpe JM, Shanmugam S, Singh SM, Lemon SM, et al. Hepatitis C Virus NS2 Protein Serves as a Scaffold for Virus Assembly by Interacting with both Structural and Nonstructural Proteins. Journal of Virology. 2011;85(1):86–97. doi: 10.1128/jvi.01070-10 WOS:000285095800007.

20. Stapleford KA, Lindenbach BD. Hepatitis C Virus NS2 Coordinates Virus Particle Assembly through Physical Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes. Journal of Virology. 2011;85(4):1706–17. doi: 10.1128/jvi.02268-10 WOS:000286420900028.

21. Popescu C-I, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, et al. NS2 Protein of Hepatitis C Virus Interacts with Structural and Non-Structural Proteins towards Virus Assembly. Plos Pathogens. 2011;7(2). doi: 10.1371/journal.ppat.1001278 WOS:000287698200016.

22. Cook GA, Dawson LA, Tian Y, Opella SJ. Three-Dimensional Structure and Interaction Studies of Hepatitis C Virus p7 in 1,2-Dihexanoyl-sn-glycero-3-phosphocholine by Solution Nuclear Magnetic Resonance. Biochemistry. 2013;52(31):5295–303. doi: 10.1021/bi4005623 WOS:000323013700018.

23. Murray CL, Jones CT, Tassello J, Rice CM. Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. Journal of Virology. 2007;81(19):10220–31. doi: 10.1128/jvi.00793-07 WOS:000249617400003.

24. Hagen N, Bayer K, Roesch K, Schindler M. The Intraviral Protein Interaction Network of Hepatitis C Virus. Molecular & Cellular Proteomics. 2014;13(7):1676–89. doi: 10.1074/mcp.M113.036301 WOS:000339251300004.

25. Cui G, Fang C, Han K. Prediction of protein-protein interactions between viruses and human by an SVM model. Bmc Bioinformatics. 2012;13. doi: 10.1186/1471-2105-13-s7-s5 WOS:000303940000006.

26. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, Liang TJ, et al. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(38):16410–5. doi: 10.1073/pnas.0907439106 WOS:000270071600074.

27. Huang Y-P, Zhang S-L, Cheng J, Wang L, Guo J, Liu Y, et al. Screening of genes of proteins interacting with p7 protein of hepatitis C virus from human liver cDNA library by yeast two-hybrid system. World Journal of Gastroenterology. 2005;11(30):4709–14. WOS:000208099500019.

28. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, Agaugue S, et al. Hepatitis C virus infection protein network. Molecular Systems Biology. 2008;4. doi: 10.1038/msb.2008.66 WOS:000261394500005.

29. Luis Nieva J, Madan V, Carrasco L. Viroporins: structure and biological functions. Nature Reviews Microbiology. 2012;10(8):563–74. doi: 10.1038/nrmicro2820 WOS:000306417400012.

30. Premkumar A, Wilson L, Ewart GD, Gage PW. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. Febs Letters. 2004;557(1–3):99–103. doi: 10.1016/s0014-5793(03)01453-4 WOS:000188648100017.

31. Pavlovic D, Neville DCA, Argaud O, Blumberg B, Dwek RA, Fischer WB, et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(10):6104–8. doi: 10.1073/pnas.1031527100 WOS:000182939400096.

32. Steinmann E, Whitfield T, Kallis S, Dwek RA, Zitzmann N, Pietschmann T, et al. Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus. Hepatology. 2007;46(2):330–8. doi: 10.1002/hep.21686 WOS:000248501600009.

33. Griffin S, StGelais C, Owsianka AM, Patel AH, Rowlands D, Harris M. Genotype-Dependent Sensitivity of Hepatitis C Virus to Inhibitors of the p7 Ion Channel. Hepatology. 2008;48(6):1779–90. doi: 10.1002/hep.22555 WOS:000261219200008.

34. Griffin SDC, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. Febs Letters. 2003;535(1–3):34–8. doi: 10.1016/s0014-5793(02)03851-6 WOS:000180734900008.

35. Clarke D, Griffin S, Beales L, Gelais CS, Burgess S, Harris M, et al. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. Journal of Biological Chemistry. 2006;281(48):37057–68. doi: 10.1074/jbc.M602434200 WOS:000242220800067.

36. Wozniak AL, Griffin S, Rowlands D, Harris M, Yi M, Lemon SM, et al. Intracellular Proton Conductance of the Hepatitis C Virus p7 Protein and Its Contribution to Infectious Virus Production. Plos Pathogens. 2010;6(9). doi: 10.1371/journal.ppat.1001087 WOS:000282373000051.

37. Atoom AM, Jones DM, Russell RS. Evidence suggesting that HCV p7 protects E2 glycoprotein from premature degradation during virus production. Virus Research. 2013;176(1–2):199–210. doi: 10.1016/j.virusres.2013.06.008 WOS:000323858500023.

38. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. Journal of Virology. 2006;80(4):1734–41. doi: 10.1128/jvi.80.4.1734–1741.2006 WOS:000235248500013.

39. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. Journal of Virology. 2006;80(11):5308–20. doi: 10.1128/jvi.02460-05 WOS:000237753400021.

40. Patargias G, Zitzmann N, Dwek R, Fischer WB. Protein-protein interactions: Modeling the hepatitis C virus ion channel p7. Journal of Medicinal Chemistry. 2006;49(2):648–55. doi: 10.1021/jm050721e WOS:000234836200025.

41. Montserret R, Saint N, Vanbelle C, Salvay AG, Simorre J-P, Ebel C, et al. NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus. Journal of Biological Chemistry. 2010;285(41):31446–61. doi: 10.1074/jbc.M110.122895 WOS:000282764600039.

42. Foster TL, Thompson GS, Kalverda AP, Kankanala J, Bentham M, Wetherill LF, et al. Structure-Guided Design Affirms Inhibitors of Hepatitis C Virus p7 as a Viable Class of Antivirals Targeting Virion Release. Hepatology. 2014;59(2):408–22. doi: 10.1002/hep.26685 WOS:000330310300009.

43. Luik P, Chew C, Aittoniemi J, Chang J, Wentworth P Jr., Dwek RA, et al. The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(31):12712–6. doi: 10.1073/pnas.0905966106 WOS:000268667600029.

44. Chandler DE, Penin F, Schulten K, Chipot C. The p7 Protein of Hepatitis C Virus Forms Structurally Plastic, Minimalist Ion Channels. Plos Computational Biology. 2012;8(9). doi: 10.1371/journal.pcbi.1002702 WOS:000309510900035.

45. Wang Y- T, Schilling R, Fink RHA, Fischer WB. Ion-dynamics in hepatitis C virus p7 helical transmembrane domains—a molecular dynamics simulation study. Biophysical Chemistry. 2014;192:33–40. doi: 10.1016/j.bpc.2014.06.001 WOS:000340220000005.

46. Whitfield T, Miles AJ, Scheinost JC, Offer J, Wentworth P Jr., Dwek RA, et al. The influence of different lipid environments on the structure and function of the hepatitis C virus p7 ion channel protein. Molecular Membrane Biology. 2011;28(5):254–64. doi: 10.3109/09687688.2011.581253 WOS:000292973600002.

47. OuYang B, Xie S, Berardi MJ, Zhao X, Dev J, Yu W, et al. Unusual architecture of the p7 channel from hepatitis C virus. Nature. 2013;498(7455):521–+. doi: 10.1038/nature12283 WOS:000320929400060.

48. Griffin SDC, Harvey R, Clarke DS, Barclay WS, Harris M, Rowlands DJ. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. Journal of General Virology. 2004;85:451–61. doi: 10.1099/vir.0.19634–0 WOS:000189152500019.

49. Chew CF, Vijayan R, Chang J, Zitzmann N, Biggin PC. Determination of Pore-Lining Residues in the Hepatitis C Virus p7 Protein. Biophysical Journal. 2009;96(2):L10–L2. doi: 10.1016/j.bpj.2008.10.004 WOS:000266377200002.

50. Brohm C, Steinmann E, Friesland M, Lorenz IC, Patel A, Penin F, et al. Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation. Journal of Virology. 2009;83(22):11682–93. doi: 10.1128/jvi.00691-09 WOS:000271084100028.

51. Meshkat Z, Audsley M, Beyer C, Gowans EJ, Haqshenas G. Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus. Journal of Viral Hepatitis. 2009;16(3):187–94. doi: 10.1111/j.1365-2893.2008.01064.x WOS:000263302200005.

52. Sakai A, St Claire MS, Faulk K, Govindarajan S, Emerson SU, Purcell RH, et al. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(20):11646–51. doi: 10.1073/pnas.1834545100 WOS:000185685700085.

53. Kalita MM, Griffin S, Chou JJ, Fischer WB. Genotype-specific differences in structural features of hepatitis C virus (HCV) p7 membrane protein. Biochimica Et Biophysica Acta-Biomembranes. 2015;1848(6):1383–92. doi: 10.1016/j.bbamem.2015.03.006 WOS:000353747500013.

54. Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. Journal of Molecular Graphics & Modelling. 1996;14(1):33–8. doi: 10.1016/0263-7855(96)00018-5 WOS:A1996UH51500005.

55. Carrere-Kremer S, Montpellier C, Lorenzo L, Brulin B, Cocquerel L, Belouzard S, et al. Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions. Journal of Biological Chemistry. 2004;279(40):41384–92. doi: 10.1074/jbc.M406315200 WOS:000224075500019.

56. Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research. 2014;42(W1):W252–W8. doi: 10.1093/nar/gku340 WOS:000339715000042.

57. Krueger J, Fischer WB. Exploring the conformational space of Vpu from HIV-1: A versatile adaptable protein. Journal of Computational Chemistry. 2008;29(14):2416–24. doi: 10.1002/jcc.20986 WOS:000259621900011.

58. Shanmugam S, Yi M. Efficiency of E2-p7 Processing Modulates Production of Infectious Hepatitis C Virus. Journal of Virology. 2013;87(20):11255–66. doi: 10.1128/jvi.01807-13 WOS:000325275800029.

59. Isherwood BJ, Patel AH. Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus. Journal of General Virology. 2005;86:667–76. doi: 10.1099/vir.0.80737–0 WOS:000227367500017.

60. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309(5734):623–6. doi: 10.1126/science.1114016 WOS:000230735200052.

61. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. Journal of Virology. 2002;76(24):13001–14. doi: 10.1128/jvi.76.24.13001–13014.2002 WOS:000179344800060.

62. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. Journal of Virology. 1999;73(8):6235–44. WOS:000081377400004.